IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111
- PMID: 3897448
- PMCID: PMC2187805
- DOI: 10.1084/jem.162.3.877
IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111
Abstract
The mechanism was sought by which bactericidal IgG for E. coli 0111 (strain 12015) increases the bactericidal efficiency of C5b-9. IgG did not affect the distribution of C3 deposition on the O-Ag capsule and the outer membrane of 12015, suggesting that bactericidal IgG was not directing complement activation to different sites on the bacterial surface. However, one-fifth of the C3 that was deposited in the presence of IgG attached covalently to the antibody molecule. Covalent complexes between purified C3b and IgG were prepared in order to study the role of C3b-IgG in the bactericidal reaction. 8-10-fold less C3b-IgG than IgG was necessary to sensitize 12015 for serum killing. When aggregates were eliminated from the C3b-IgG and IgG preparations by sucrose density gradient ultracentrifugation, C3b-IgG remained three- to fourfold more effective than IgG on a molecule-for-molecule bound basis in mediating the serum bactericidal reaction. These results suggest that formation of C3b-IgG during the serum bactericidal reaction is critical for killing, and have important implications for the development of effective bactericidal vaccines.
Similar articles
-
Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.J Immunol. 1983 Nov;131(5):2563-9. J Immunol. 1983. PMID: 6355296
-
Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.J Immunol. 1983 Nov;131(5):2570-5. J Immunol. 1983. PMID: 6355297
-
The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.Biochem J. 1981 May 1;195(2):471-80. doi: 10.1042/bj1950471. Biochem J. 1981. PMID: 7316962 Free PMC article.
-
An affinity for complement C3 as a possible reason for the potency of naturally occurring antibodies in mediating tissue homeostasis.Beitr Infusionsther. 1989;24:193-9. Beitr Infusionsther. 1989. PMID: 2481539 Review.
-
Complement amplification revisited.Mol Immunol. 2006 Jan;43(1-2):2-12. doi: 10.1016/j.molimm.2005.06.020. Mol Immunol. 2006. PMID: 16023211 Review.
Cited by
-
Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.J Clin Invest. 1985 Nov;76(5):1765-72. doi: 10.1172/JCI112167. J Clin Invest. 1985. PMID: 3932472 Free PMC article.
-
Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes.Blood. 2021 Nov 25;138(21):2106-2116. doi: 10.1182/blood.2020009487. Blood. 2021. PMID: 34189574 Free PMC article.
-
Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments.Infect Immun. 1993 Jun;61(6):2532-6. doi: 10.1128/iai.61.6.2532-2536.1993. Infect Immun. 1993. PMID: 8500889 Free PMC article.
-
Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.J Infect Dis. 2015 Sep 1;212(5):784-92. doi: 10.1093/infdis/jiv081. Epub 2015 Feb 12. J Infect Dis. 2015. PMID: 25676468 Free PMC article.
-
Infectious diseases associated with complement deficiencies.Clin Microbiol Rev. 1991 Jul;4(3):359-95. doi: 10.1128/CMR.4.3.359. Clin Microbiol Rev. 1991. PMID: 1889047 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous